BFRI Biofrontera Inc.

Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.

$2.87  +0.12 (4.36%)
As of 05/26/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  
IPO date:  10/29/2021
Outstanding shares:  17,104,749
Average volume:  294,905
Market cap:   $47,038,060
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -1.72
PB ratio:   2.82
PS ratio:   1.20
Return on equity:   -492.85%
Net income %:   -143.04%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy